Epidarex Capital
Closing Date: –
Equity investment for UK early-stage life science and health technology start-ups and university spinouts, typically at seed or Series A stage, that are developing research-led innovations with commercial potential.
Epidarex is a transatlantic venture capital firm that provides equity investment to early-stage life science and health technology companies in the UK and US. It focuses on high growth opportunities in emerging and under-ventured research hubs, including university spinouts and start-ups developing novel healthcare technologies.
The firm typically invests at seed or Series A stage, supporting the creation and development of companies based on scientific research from universities and research institutions. Investment areas include biotechnology and pharmaceuticals, medical devices and health tech.
Epidarex works with management teams to support the translation of research into commercial businesses for the global healthcare market. Its network includes investment professionals, scientists, industry executives, health practitioners, regulatory advisors and business development specialists. This network is used to help portfolio companies develop products, attract follow-on investment and progress towards market entry.
| Funding body | Epidarex |
|---|---|
| Maximum value | £5,000,000 |
| Reference ID | S54973 |
| Category | Business Support Research & Development |
| Fund or call | Fund |